Skip to main content

Advertisement

Log in

Identification of sentinel lymph node location based on body surface landmarks in early breast cancer patients

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

It would be extremely useful if the location of the sentinel lymph node in breast cancer could be identified based on body surface landmarks. However, the identification of the sentinel node location by using surface landmarks in many reports is based on empirical methodologies.

Methods

We studied the distribution of the sentinel node location in 70 breast cancer patients based on the lateral line of the major pectoral muscle, the axillary skin fold that divides the trunk and the upper arm, and the nipple of the breast.

Results

The location of the sentinel node could be predicted using an ellipse with a semi-major axis of 2.8 cm and a semi-minor axis of 2.2 cm with a probability of 95% for a patient with the mean body size.

Conclusion

Our data demonstrate that the location of the sentinel nodes can be predicted within a narrow area based on body landmarks.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818–22.

    Article  PubMed  CAS  Google Scholar 

  2. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864–7.

    Article  PubMed  CAS  Google Scholar 

  3. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–53.

    Article  PubMed  Google Scholar 

  4. Bass SS, Cox CE, Ku NN, Berman C, Reintgen DS. The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg. 1999;189:183–94.

    Article  PubMed  CAS  Google Scholar 

  5. Kern KA. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg. 1999;189:539–45.

    Article  PubMed  CAS  Google Scholar 

  6. Reitsamer R, Peintinger F, Rettenbacher L, Prokop E, Sedlmayer F. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients. World J Surg. 2003;27:1291–4.

    Article  PubMed  Google Scholar 

  7. Koizumi M, Nomura E, Yamada Y, Takiguchi T, Makita M, Iwase T, et al. Radioguided sentinel node detection in breast cancer patients: comparison of 99 mTc phytate and 99 mTc rhenium colloid efficacy. Nucl Med Commun. 2004;25:1031–7.

    Article  PubMed  Google Scholar 

  8. Koizumi M, Nomura E, Yamada Y, Takiguchi T, Tanaka K, Yoshimoto M, et al. Sentinel node detection using 99 mTc-rhenium sulphide colloid in breast cancer patients: evaluation of 1 day and 2 day protocols, and a dose-finding study. Nucl Med Commun. 2003;24:663–70.

    Article  PubMed  CAS  Google Scholar 

  9. Anderson TA. An introduction of multivariate statistical analysis. 3rd ed. New Jersey: Wiley; 2003.

    Google Scholar 

  10. Motomura K, Egawa C, Komoike Y, Kataoka T, Nagumo S, Koyama H, et al. Sentinel node biopsy for breast cancer: technical aspects and controversies. Breast Cancer. 2007;14:25–30.

    Article  PubMed  Google Scholar 

  11. Rodier JF, Velten M, Wilt M, Martel P, Ferron G, Vaini-Elies V, et al. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial. J Clin Oncol. 2007;25:3664–9.

    Article  PubMed  Google Scholar 

  12. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet. 1997;349:1668–9.

    Article  PubMed  CAS  Google Scholar 

  13. Boolbol SK, Fey JV, Borgen PI, Heerdt AS, Montgomery LL, Paglia M, et al. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma. Ann Surg Oncol. 2001;8:20–4.

    Article  PubMed  CAS  Google Scholar 

  14. Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kroger R, Peterse JL, et al. Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer. 2003;39:1068–73.

    Article  PubMed  CAS  Google Scholar 

  15. Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM, et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer. 2002;95:982–8.

    Article  PubMed  Google Scholar 

  16. Dixon JM, Dobie V, Chetty U. The importance of interpectoral nodes in breast cancer. Eur J Cancer. 1993;29A:334–6.

    Article  PubMed  CAS  Google Scholar 

  17. Shen J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, et al. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer. 2004;101:1330–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keiichiro Tada.

About this article

Cite this article

Ueda, N., Tada, K., Miyata, S. et al. Identification of sentinel lymph node location based on body surface landmarks in early breast cancer patients. Breast Cancer 16, 219–222 (2009). https://doi.org/10.1007/s12282-008-0086-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-008-0086-4

Keywords

Navigation